Trademark: 97333954
Status Date
Tuesday, May 23, 2023
Registration Number
7059514
Registration Date
Tuesday, May 23, 2023
Filing Date
Monday, March 28, 2022
Published for Opposition
Tuesday, March 7, 2023
5 Pharmaceutical products for use in the field of neuroscience, namely, for the treatment of neurological and nervous system diseases and disorders; pharmaceutical preparations for the treatment of seizures associated with Dravet Syndrome and Lennox-Gastaut Syndrome
May 23, 2023
Notice Of Registration Confirmation Emailed
May 23, 2023
Registered-Principal Register
Mar 7, 2023
Official Gazette Publication Confirmation E-Mailed
Mar 7, 2023
Published For Opposition
Feb 15, 2023
Notification Of Notice Of Publication E-Mailed
Jan 31, 2023
Approved For Pub - Principal Register
Jan 31, 2023
Notification Of Examiners Amendment E-Mailed
Jan 31, 2023
Examiners Amendment E-Mailed
Jan 31, 2023
Examiners Amendment -Written
Jan 30, 2023
Notification Of Letter Of Suspension E-Mailed
Jan 30, 2023
Letter Of Suspension E-Mailed
Jan 30, 2023
Suspension Letter Written
Jan 14, 2023
Teas/Email Correspondence Entered
Jan 13, 2023
Correspondence Received In Law Office
Jan 13, 2023
Teas Response To Office Action Received
Sep 27, 2022
Notification Of Non-Final Action E-Mailed
Sep 27, 2022
Non-Final Action E-Mailed
Sep 27, 2022
Non-Final Action Written
Sep 27, 2022
Assigned To Examiner
Aug 24, 2022
Teas Voluntary Amendment Received
Apr 1, 2022
New Application Office Supplied Data Entered
Mar 31, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24